register

News & Trends - MedTech & Diagnostics

Northern Sydney Cancer Centre partners with Sun Nuclear as newest reference site for radiation oncology

Health Industry Hub | March 24, 2021 |

MedTech News: Sun Nuclear Corporation, part of Mirion Technologies, announced that Australia’s Northern Sydney Cancer Centre (NSCC) is now a reference site for the SunCHECK Quality Management Platform. The centre joins leading clinics worldwide already in the reference site program.

Globally, SunCHECK technology is used by more than 1,000 users in nearly 60 countries – for integrated, automated and independent Quality Assurance in Radiation Therapy.

The NSCC treats more than 1,400 patients annually, using three Varian Medical Systems linear accelerators and a robust auto-planning program. The NSCC also uses an Elekta brachytherapy system.

In partnering with Sun Nuclear, the NSCC will support development of best practices for research and clinical use, advise on ongoing platform development, and serve as a regional resource for a rapidly-growing community of SunCHECK users. The NSCC is an integrated cancer care network, provided by the Northern Sydney Local Health District (NSLHD).

Jeremy Booth, Head of Medical Physics for the NSCC, stated that the centre is a pioneer in advanced treatments, initiating its IMRT program in 2001 and its SBRT program in 2007. Today, the NSCC remains focused on continually investigating the feasibility of technological changes, including motion management.   

“As a busy clinic with an active research program, we need an efficient, proven quality assurance mechanism,” said Booth. “SunCHECK provides the comprehensive functionality and departmental integration we were looking for and offers the efficiency our workload demands.”  

The SunCHECK Platform automates and integrates Quality Management, enabling Radiation Therapy departments to standardize Patient and Machine Quality Assurance (QA) workflows among staff, machines, and locations. A secure, browser-based network architecture connects multiple systems and can support different geographic locations, offering a top-down view through a single dashboard, supported by a single database.

SunCHECK Patient software incorporates Plan Checks, Secondary Calculations, Pre-Treatment QA and In-Vivo Monitoring all in a single workflow. SunCHECK Machine software integrates all Machine QA needs, including Daily, Monthly, and Annual QA; automated imaging, MLC and VMAT QA; and data trending. Plus, device integration with the Daily QA 3, IC PROFILER and ArcCHECK arrays enables further automation and centralization of data.


Medical and Science

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

Health Industry Hub | September 6, 2024 |

Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes […]

More


ESG

First report exposes glaring gaps in healthcare sector sustainability

First report exposes glaring gaps in healthcare sector sustainability

Health Industry Hub | September 6, 2024 |

ESG: The first comprehensive report outlining sustainability and decarbonisation efforts in the Australian healthcare sector has been released, aimed at […]

More


News & Trends - Pharmaceuticals

Expanded access to Shingrix is a start: 'We need reform for all current and future vaccines'

Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’

Health Industry Hub | September 6, 2024 |

Pharma News: Access to GSK’s Shingrix vaccine, following the 2023-24 federal budget decision, has been limited to “immunocompromised patients aged […]

More


News & Trends - Pharmaceuticals

NSW government fails to back mental health inquiry findings with essential funding

NSW government fails to back mental health inquiry findings with essential funding

Health Industry Hub | September 6, 2024 |

NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]

More


This content is copyright protected. Please subscribe to gain access.